Literature DB >> 32485529

The Melanoma and Breast Cancer Association: An Overview of their 'Second Primary Cancers' and the Epidemiological, Genetic and Biological correlations.

Arunan Jeyakumar1, Terence Chua2, Alfred King-Yin Lam1, Vinod Gopalan3.   

Abstract

This study reviews the relevant epidemiological studies associating cutaneous melanoma and breast carcinomas and provides an overview of the possible genetic, biological and bias factors that underpin this relationship. Standardised incidence ratio (SIR) for primary cutaneous melanoma after breast carcinoma ranged from 1.16 to 5.13 and ranged from 1.03 to 4.10 for primary breast carcinoma after cutaneous melanoma. Epidemiological studies highlight age, gender and use of radiotherapy and chemotherapy as potential risk factors for second primary cancers (SPCs). Mutations in BRCA2, CDKN2A, CDK4 and BAP1 may partly underlie any SPC association. The impact of socio-cultural factors and surveillance bias may be attributed to the findings of SPC partially or entirely. In conclusion, this study has highlighted the association between breast carcinoma and melanoma and identified various factors for further research and the optimised management of patients with both cancers.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  breast cancer; cutaneous melanoma; epidemiology; genetics; second primary cancers

Year:  2020        PMID: 32485529     DOI: 10.1016/j.critrevonc.2020.102989

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  5 in total

1.  Incidence of other cancer diagnoses in women with breast cancer: a retrospective cohort study with 42,248 women.

Authors:  Ivan Nikolov; Karel Kostev; Matthias Kalder
Journal:  Breast Cancer Res Treat       Date:  2022-07-12       Impact factor: 4.624

2.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

3.  Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study.

Authors:  Xiaoyi Lin; Xin Lin; Yingzi Li; Yuchen Zhang; Jiali Lin; Guochun Zhang
Journal:  Int J Gen Med       Date:  2021-11-24

4.  Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond.

Authors:  Joanna Bojarska; Martin Breza; Milan Remko; Malgorzata Czyz; Anna Gajos-Michniewicz; Michał Zimecki; Krzysztof Kaczmarek; Izabela D Madura; Jakub M Wojciechowski; Wojciech M Wolf
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

5.  Cancer Prevention for Survivors: Incidence of Second Primary Cancers and Sex Differences-A Population-Based Study from an Italian Cancer Registry.

Authors:  Rosalia Ragusa; Antonina Torrisi; Alessia Anna Di Prima; Antonietta A Torrisi; Antonella Ippolito; Margherita Ferrante; Anselmo Madeddu; Vincenzo Guardabasso
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.